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Penning2 and Mitchell Lewis1*
Background: Mammalian 3a-hydroxysteroid dehydrogenases (3a-HSDs)
modulate the activities of steroid hormones by reversibly reducing their C3
ketone groups. In steroid target tissues, 3a-HSDs act on 5a-dihydrotestosterone,
a potent male sex hormone (androgen) implicated in benign prostate hyperplasia
and prostate cancer. Rat liver 3a-HSD belongs to the aldo-keto reductase (AKR)
superfamily and provides a model for mammalian 3a-, 17b- and 20a-HSDs,
which share >65% sequence identity. The determination of the structure of 3a-
HSD in complex with NADP+ and testosterone (a competitive inhibitor) will help
to further our understanding of steroid recognition and hormone regulation by
mammalian HSDs.
Results: We have determined the 2.5 Å resolution crystal structure of
recombinant rat liver 3a-HSD complexed with NADP+ and testosterone. The
structure provides the first picture of an HSD ternary complex in the AKR
superfamily, and is the only structure to date of testosterone bound to a protein.
It reveals that the C3 ketone in testosterone, corresponding to the reactive
group in a substrate, is poised above the nicotinamide ring which is involved in
hydride transfer. In addition, the C3 ketone forms hydrogen bonds with two
active-site residues implicated in catalysis (Tyr55 and His117).
Conclusions: The active-site arrangement observed in the 3a-HSD ternary
complex structure suggests that each positional-specific and stereospecific
reaction catalyzed by an HSD requires a particular substrate orientation, the
general features of which can be predicted. 3a-HSDs are likely to bind
substrates in a similar manner to the way in which testosterone is bound in the
ternary complex, that is with the A ring of the steroid substrate in the active
site and the b face towards the nicotinamide ring to facilitate hydride transfer.
In contrast, we predict that 17b-HSDs will bind substrates with the D ring of
the steroid in the active site and with the a face towards the nicotinamide
ring. The ability to bind substrates in only one or a few orientations could
determine the positional-specificity and stereospecificity of each HSD.
Residues lining the steroid-binding cavities are highly variable and may select
these different orientations. 
Introduction
Rat liver 3a-hydroxysteroid/dihydrodiol dehydrogenase
(3a-HSD) is a member of an important class of enzymes
involved in the biosynthesis and inactivation of steroid
molecules and the regulation of steroid hormone action.
The enzyme is a 37029 Da monomeric oxidoreductase
(EC 1.1.1.213) with dual NAD(P)(H) cofactor specificity
[1] that interconverts biologically active 3-ketosteroids and
3a-hydroxysteroids, such as the male sex hormones
(androgens) [2]. Three isoforms of 3a-HSD have been
reported in human tissues [3–5]. The rat liver enzyme
used in this study shares high sequence identity with
these isoforms and provides a structural model for the
human liver and prostate subtypes.
All steroid hormones function via a common pathway: by
diffusing into cells and occupying receptors. These recep-
tors then bind hormone response elements on the DNA
and interact with the transcriptional machinery to activate
or repress transcription of target genes [6]. A carbonyl
group in the A ring of androgens is required for high
potency and can occur in the 4-en-3-oxo configuration, as
in testosterone (Fig. 1a), or in a 3-oxo group, as in 5a-dihy-
drotestosterone (5a-DHT) (Fig. 1b). Testosterone is the
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predominant androgen secreted by the testes, but is con-
verted to 5a-DHT by 5a-reductase in the prostate and
other tissues of the male genital tract. 5a-DHT is the
most potent of androgens: it binds the androgen receptor
with a Kd of 10–11 M and is implicated in the pathogenesis
of benign prostate hyperplasia (BPH) and prostate cancer.
In steroid hormone target tissues, hydroxysteroid dehy-
drogenases (HSDs) regulate the potencies of steroid hor-
mones. This regulation is achieved by the reversible
reduction of specific carbonyl groups which dramatically
alters the affinities of the hormones for receptors. 
HSDs can belong to one of two superfamilies: the aldo-
keto reductases (AKRs) and the short-chain dehydroge-
nases/reductases (SDRs). The AKRs are monomeric and
have an a/b-barrel fold [7,8], whereas the SDRs are
dimeric or tetrameric and contain a Rossmann nucleotide-
binding fold [9]. 
Rat liver 3a-HSD and the human liver and prostate iso-
forms belong to the AKR superfamily and reversibly
convert 5a-DHT to the weak androgen 3a-androstanediol
(3a-Adiol) (Fig. 1c). 3a-HSD is the only known steroid-
metabolizing enzyme present in hyperplastic prostate
tissue with a Vmax/Km similar to that of 5a-reductase, sug-
gesting it is important in regulating 5a-DHT concentra-
tion [10]. Moreover, 3a-HSD has been shown to catalyze
the major degradational route of 5a-DHT in homogenates
of rat prostate and epididymis [11]. In vivo, the direction
of the reaction will be influenced by the availability of the
oxidative or reductive NAD(P)(H) cofactors, and prostatic
3a-HSD may actually work predominantly in the oxida-
tive direction, in concert with 5a-reductase, to maintain
high levels of 5a-DHT [12]. In addition, although 3a-
Adiol has traditionally been seen as a mere end point in
androgen degradation, it was recently assigned a new role
as a hormone involved in murine parturition (birth) [13].
Thus, 3a-HSDs not only regulate the occupancy of the
androgen receptor by modulating 5a-DHT levels, but also
catalyze the final step in the synthesis of an active steroid
hormone, 3a-Adiol.
Rat liver 3a-HSD is a member of the HSD subfamily of the
AKR superfamily, denoted AKR1C [8], and is closely
related to other mammalian HSDs (>65% identity)
(Table 1). Previously, the only information about ligand
binding in AKRs came from members of the more distantly
related aldose reductase subfamily (AKR1B) (Table 1) com-
plexed with non-steroidal ligands. These structures include
aldose reductase complexed with cofactor and either citrate
[14], cacodylate [14], glucose-6-phosphate [14] or the
potent aldose reductase inhibitor (ALRI) zopolrestat [15],
as well as murine fibroblast growth factor-induced protein
(FR-1) complexed with cofactor and zopolrestat [16].
In this study, we have determined the structure of rat
liver 3a-HSD complexed with NADP+ and the competi-
tive inhibitor testosterone. This is the first ternary
complex structure of an HSD in the AKR superfamily.
The structure reveals several differences from the aldose
and aldehyde reductases, notably the sequences and
conformations of two loops that are located in the ligand-
binding cavity and cofactor tunnel. The structure pro-
vides a model for other mammalian HSDs (Table 1),
including human liver dihydrodiol dehydrogenases (DD1,
DD2 and DD4, which function as 20a-HSD, hepatic bile
acid binding protein and type I 3a-HSD/chlordecone
reductase, respectively [4,5,17–19]), mouse 17b-HSD [20]
and rat and rabbit ovarian 20a-HSDs [21,22]. In addition,
the first ternary complexes of HSDs in the SDR super-
family were recently reported [23–25] and we can now
compare complexes of HSDs belonging to both superfam-
ilies. This comparison provides insights into the func-
tional and evolutionary relationships between these
families and their common mechanisms for regulating
steroid receptor occupancy.
Results and discussion
Structure refinement and quality of the model
The quality of the refined 3a-HSD–NADP+–testosterone
model can be assessed from the statistics in Table 2. All
data between 8Å and 2.5 Å were used in the refinement,
yielding a crystallographic R factor of 18.5% and a free R
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Figure 1
Potent and weak androgens differ at positions
3, 4 or 5 on the steroid nucleus. (a)
Testosterone is a potent androgen secreted
by the testes. (b) 5a-Dihydrotestosterone is
the most potent androgen, with an affinity for
the androgen receptor of 10–11 M. (c) 3a-
Androstanediol is a weak androgen, with an
affinity for the androgen receptor of 10–6 M.
The four rings in testosterone are designated
A, B, C and D. Substituents above the plane
containing the four rings (e.g. the C18 and
C19 methyl groups) are b-oriented while
substituents below the plane (e.g. the hydroxyl
group in 3a-androstanediol) are a-oriented.
factor of 24.2 % based on a subset of 10% of the reflec-
tions. There are two molecules in the asymmetric unit
related by noncrystallographic symmetry (see Materials
and methods). The refined model includes two complete
ternary complexes, each of which contains an NADP+
molecule and a testosterone molecule. In addition, the
model includes 58 water molecules, of which 50 are
related by the noncrystallographic symmetry (25 water
molecules bound to each protein molecule). Of the 322
amino acids in the protein, 319 are modeled into the elec-
tron density. The three C-terminal residues not included
in the model were disordered. Individual isotropic tem-
perature (B) factors were also refined and resulted in
slightly higher B values in molecule A as compared to mol-
ecule B (Table 2). The model was refined with tight non-
crystallographic symmetry restraints for all but seven
residues in crystal contacts. With the exception of these
seven residues, the two molecules in the asymmetric unit
are identical. The Ramachandran plot for the ternary
complex positions  98% of the backbone dihedral angles in
the core regions, as defined by Kleywegt and Jones [26].
In addition, the 2Fo–Fc omit electron density correspond-
ing to the testosterone molecule is of good quality (Fig. 2).
Overall structure of the ternary complex
The structure of the ternary complex is shown in Figures
2a and 2b. The protein chain forms an a/b barrel with two
additional helices. Overall, the ternary complex is similar
in structure to the binary complex with NADP+ [27], and
has essentially the same secondary structure assignments.
A superposition of the two structures using 278 out of 322
residues showed a root mean square (rms) deviation
between Ca atoms of only 0.3Å. There are, however,
three loops that undergo conformational changes and tran-
sitions from disordered to ordered structures in the ternary
complex: the loop between the first b strand and a helix
in the a/b barrel (b1–a1 loop; residues 23–32); loop B
(residues 217–238); and the C-terminal tail (residues
299–322). All of these loops become more ordered because
of contacts made with the testosterone molecule. Portions
of the b1–a1 loop were disordered in both the apoenzyme
[28] and binary complex [27] structures; however, in the
ternary complex, the entire loop is ordered (with the
exception of sidechains 27 and 28). The ordering of this
loop is most likely to be a result of contacts with loop B,
which itself contacts testosterone. In addition, one of the
residues of loop b1–a1, Thr24, is located within the
steroid-binding cavity (Fig. 2c). Although loop B was par-
tially disordered in the apoenzyme and binary complex, it
is ordered in the ternary complex as a result of van der
Waals contacts involving Thr226, Trp227 and testosterone
(Fig. 2d). Similarly, the C-terminal tail was partially disor-
dered in the apoenzyme and binary complex structures,
but is ordered in the ternary complex (with the exception
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Table 1
Amino acid sequence similarity in three AKR subfamilies.
Protein AKR* Identity† Similarity† Subfamily‡
nomenclature (%) (%)
Human liver aldehyde reductase AKR1A1 41 65 Aldehyde reductase
Porcine aldehyde reductase AKR1A2 41 65 Aldehyde reductase
Rat liver aldehyde reductase AKR1A3 40 64 Aldehyde reductase
Human placental aldose reductase AKR1B1 47 66 Aldose reductase
Rabbit aldose reductase AKR1B2 47 65 Aldose reductase
Mouse kidney aldose reductase AKR1B3 47 65 Aldose reductase
Rat lens aldose reductase AKR1B4 46 65 Aldose reductase
Bovine aldose reductase AKR1B5 47 67 Aldose reductase
Porcine muscle aldose reductase AKR1B6 46 66 Aldose reductase
Mouse vas deferens protein AKR1B7 45 66 Aldose reductase
Mouse FR-1 protein AKR1B8 45 64 Aldose reductase
Human liver 20a-HSD/DD1§ AKR1C1 69 80 HSD
Human liver BABP/DD2§ AKR1C2 69 81 HSD
Human liver type II 3a-HSD AKR1C3 70 80 HSD
Human liver type I 3a-HSD/CR/DD4§ AKR1C4 70 82 HSD
Rabbit ovary 20a-HSD AKR1C5 73 82 HSD
Mouse liver 17b-HSD AKR1C6 71 83 HSD
Bovine lung prostaglandin F2a synthase AKR1C7 70 80 HSD
Rat ovary and luteal 20a-HSD AKR1C8 67 80 HSD
Rat liver 3a-HSD AKR1C9 100 100 HSD
Frog lens r crystallin AKR1C10 55 74 HSD
*New AKR nomenclature [8] is given after the common name.
†Percentage of identical or similar amino acids as compared to rat liver
3a-HSD; amino acid sequences were aligned with the GCG package
[53]. The percentage identity and percentage similarity in the aldose
and aldehyde reductase subfamilies do not include gaps.  There are no
gaps in the HSD subfamily alignments. ‡For clarity we show only the
HSD subfamily (steroid hormone oxidoreduction) and the aldose and
aldehyde reductase subfamilies (aldose reduction). §DD1 = dihydrodiol
reductase; BABP = bile acid binding protein; CR = chlordecone
reductase.  
of residues 320–322) as a result of making van der Waals
contacts involving Asn306, Tyr310 and testosterone (Fig.
2c). The only other long loop (A) does not undergo a large
change relative to the binary complex even though
residues of this loop form contacts with testosterone. 
The cofactor and inhibitor bind in two different regions of
the protein and come together in the active site, near
Tyr55 and His117. The testosterone molecule is bound at
the C-terminal end of the barrel, essentially parallel to the
barrel axis (Fig. 2a). Five loops form a deep cavity into
which testosterone is bound and thereby shielded from the
solvent. The nucleotide cofactor, NADP+, is also bound at
the C-terminal end of the barrel, but closer to its core
(Fig. 2a). The cofactor is roughly perpendicular to the
barrel axis, with the adenine ring at the periphery and the
nicotinamide ring in the active site (Fig. 2b). The cofactor
is sequestered under a short tunnel, which is formed
mainly by residues of loop B and the b1–a1 loop (discussed
below). In contrast to the binary complex structure NADP+
is bound in only one conformation because of the forma-
tion of the cofactor tunnel and ordering of loop B.
Testosterone-binding cavity
Testosterone is not a substrate for 3a-HSD, but rather 
a competitive inhibitor of androsterone oxidation (J
Ricigliano and TM Penning, unpublished data) with a Kd
of 4.2mM [29]. The C3 ketone of testosterone cannot be
reduced because of the adjacent 4,5 double bond, which
also alters the conformation of the A ring relative to the rest
of the steroid nucleus as compared to 5a-reduced steroids.
However, the mode of testosterone binding is probably
similar to that of a substrate, including the coincidence of
its C3 ketone with the reactive ketone in a substrate.
The testosterone molecule is bound in a cylindrical cavity
formed by ten residues (Thr24, Leu54, Tyr55, His117,
Phe118, Phe129, Thr226, Trp227, Asn306 and Tyr310) in
five loops at the C-terminal end of the barrel. These
residues are a subset of those previously identified as can-
didates for the steroid-binding site [27,30], with the
exceptions of Thr24 and Thr226. The loops forming the
steroid-binding cavity include the long loops A and B
(residues 117–143 and 217–238, respectively) and the C-
terminal tail (residues 299–322), as well as two shorter b–a
connections: b1–a1 (residues 23–32) and b2–a2 (residues
51–57) (Fig. 2). The cavity also includes the nicotinamide
ring of NADP+, which lies at its base. The O1 atom of the
C3 ketone on testosterone displaces a water molecule
observed in the active site of the binary complex [27].
Based upon the binary complex, we speculated that an
apolar cleft forming a crystal contact might be the steroid-
binding site. It is clear, however, that the steroid-binding
cavity in the ternary complex is not the same as the crystal
contact, although several residues in the crystal contact
(Leu54, Phe118, Phe129 and Tyr310) contribute to the
binding of testosterone. The formation of the steroid-
binding cavity involves conformational changes of three
loops, including the C-terminal tail which contains Tyr310
(discussed below).
The sidechains interacting with the testosterone molecule
are shown in Figures 2c and 2d. These interactions bury
360Å2, or 80% of the solvent-accessible surface area of the
testosterone molecule, and 215Å2 of the solvent-accessi-
ble surface area in the cavity. The A, B and C rings of
testosterone interact extensively with the protein, while
the D ring makes only a few contacts. The b face of
testosterone (see definitions in Fig. 1 legend) interacts
with loop B (particularly Trp227), while the a face inter-
acts mainly with Leu54 (Fig. 2d).
The protein forms two hydrogen bonds with the O1 atom
in the C3 ketone of the testosterone molecule, which
would be the site of catalysis in a substrate. As a conse-
quence of this hydrogen bonding, the O1 atom is the
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Table 2
Data collection, structural and refinement statistics for the 
3a-HSD–NADP+–testosterone complex at 2.5 Å resolution.
Unit cell dimensions
a, b, c (Å) 96.4, 157.1, 49.0
a, b, g (°) 90
Space group P21212
Temperature (°C) 25
Number of reflections 25 244
Resolution (Å) 8.0–2.5  (2.7–2.5)
Completeness (%) 98.2  (92.7)
I >3s(I) (%) 78.4  (52.2)
Rmerge* (%) 9.8  (32.7)
Multiplicity 4.5  (3.6)
Rcryst † (%) 18.5  (25.5)
Rfree † (%) 24.2  (31.6)
Rms deviations from target geometry
bond lengths (Å) 0.009
bond angles (°) 1.5
improper angles (°) 1.4
dihedral angles (°) 24.1
Number of non-hydrogen atoms
all atoms 5358
protein 5162
NADP 96
testosterone 42
water 58
Average B factors (Å2)
protein 29.6/26.4
NADP 26.2/19.8
testosterone 36.9/33.0
water 24.3/23.4
*Rmerge (I) = (SS | (I(i)– < I(hkl)> | )/ SS I(i), summed over all reflections
and all observations, where I(i) is the ith observation of the intensity of
the hkl reflection and < I(hkl)> is the mean intensity of the hkl
reflection; a measure of the precision of data collection.
†Rcryst (F) = Sh | |Fobs(h) |– |Fc(h) | | /Sh I Fobs(h) |, where Fobs and Fc are
the observed and calculated structure-factor amplitudes for the reflection
with Miller indices h = (h,k,l). The free R factor is calculated for a ‘test’ set
of reflections which were not included in atomic refinement [54].
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Figure 2
The steroid-binding cavity in 3a-HSD is
formed by five loops. Testosterone is
surrounded by apolar residues and forms
hydrogen bonds in the active site with Tyr55
and His117. (a) Stereoview ribbon drawings
of the 2.5 Å resolution ternary complex. Loops
that interact with the testosterone molecule
are labeled. (b) Stereoview ribbon drawings
of a view rotated approximately 90° about the
horizontal axis relative to (a). The polypeptide
chain is in gray, the NADP+ molecule is
shown in blue, the testosterone molecule is
shown in red and two active-site residues
(Tyr55 and His117) which form hydrogen
bonds with the C3 ketone of testosterone are
shown in green. (Ribbon drawings were made
using MOLSCRIPT [55] and rendered with
RASTER3D [56,57].) (c) The unbiased
2Fo–Fc difference electron-density map
contoured at 1s (calculated prior to inclusion
of testosterone in the atomic coordinates) is
shown superimposed on the testosterone
molecule. The view is in a similar orientation to
(a). Residues in the steroid-binding cavity that
interact with the edges of testosterone are
shown. (d) Side view, rotated 90° about the
vertical axis relative to part (c). Residues in the
steroid-binding cavity that interact with the a
and b faces of testosterone are shown, as are
two residues that form hydrogen bonds with
the C3 ketone (His117 and Tyr55).
(a)
(b)
(c)
(d)
most ordered atom in testosterone, with a B factor of
15 Å2 in molecule B (25 Å2 in molecule A). These hydro-
gen bonds involve Tyr55 and His117 in the active site,
and form a triangular-shaped network (Fig. 2d) similar to
that observed between steroids and the catalytic residues
of 17b-HSD [23,24] and 7a-HSD [25] in the SDR super-
family (discussed below). In contrast, the hydroxyl group
at C17 is unliganded. Overall, at the proximal, active-site
end of the cavity, testosterone makes many contacts with
the protein, including two hydrogen bonds, and is solvent
inaccessible, whereas at the distal end of the cavity, it
makes fewer contacts and is solvent-exposed. As deter-
mined by the temperature factors, the testosterone mol-
ecule is more ordered at the proximal end: the average B
factors increase from 27 Å2, in the A ring, to 33 Å2, 37 Å2
and 47 Å2 in the B, C and D rings, respectively. 
A well formed steroid-binding cavity is found only in the
presence of testosterone. Half of the cavity is present in
the apoenzyme [28] and binary complex [27] (left-hand
side of the cavity in Figs 2a, b). The other half of the
cavity, however, is present only in the ternary complex
(right-hand side of the cavity in Figs 2a, b). This half of
the cavity is made up of residues in loop B, the C-terminal
tail, and the b1–a1 loop that were disordered and/or flexi-
ble in the apoenzyme and binary complex structures.
Thus, a comparison of all three crystal structures suggests
that the b1–a1 loop, loop B and the C-terminal tail have
less conformational mobility when a steroid molecule or
other ligand is present to form stabilizing contacts. The
flexibility of these loops may be of functional importance.
3a-HSD is known to bind and turn over diverse substrates
in addition to steroids, including aromatic ketones (single
rings), polycyclic aromatic hydrocarbon trans-dihydrodiols
(lacking axial methyl groups) and bile acids (having axial
methyl groups and being significantly bent at the A ring).
The flexibility of loop B and the C-terminal tail may
enable the enzyme to accommodate substrates of varying
shapes and sizes by adopting different conformations. 
The ternary complex also provides a structural interpreta-
tion of two site-directed mutants of 3a-HSD. Replace-
ment of Trp227 or Trp86 with a tyrosine residue increased
the Kd for testosterone by 22-fold or sevenfold, respec-
tively [29]. The ternary complex structure reveals that
Trp227 in loop B packs against the testosterone molecule,
providing most of the contacts to the b face of the steroid.
Although Trp86 does not directly contact the steroid, it
packs against several residues that are located in the
steroid-binding cavity (e.g. Leu54 and Phe129).
NADP+-binding site: the cofactor tunnel lacks a ‘safety belt’
NADP+ binding in 3a-HSD differs from that in the
aldose/aldehyde reductase subfamilies. Although many
hydrogen-bonding interactions between the protein and
the cofactor are conserved, 3a-HSD lacks a salt-linked
‘safety belt’ that fastens two loops which form a cofactor
tunnel in aldehyde reductase [31], aldose reductase
[32,33] and murine  FR-1 [16]. In addition, although there
is a short cofactor tunnel through which NADP+ is
threaded, it is different in sequence and conformation in
3a-HSD than in other AKR enzymes.
The cofactor tunnel in 3a-HSD is formed mainly by van der
Waals contacts between the b1–a1 loop (residues 26–27),
loop B (residues 222–226) and Arg270. A hydrogen bond is
also formed between the sidechain of Asp224 and the main-
chain nitrogen atom of Glu27. Although the cofactor tunnel
is in approximately the same position as in aldose reductase
and FR-1, the structures of the loops forming it are different
because of sequence insertions and substitutions. The
b1–a1 loop has a three residue insertion relative to the
aldose/aldehyde reductases, which alters its position and
conformation; loop B has an arginine insertion after position
222 which contributes to its altered conformation (Fig. 3).
In the aldose/aldehyde reductase subfamilies, a safety belt
is created by a salt bridge between Asp224, Lys25 and
Lys270 (residue numbering as aligned to 3a-HSD)
(Fig. 4). Of these residues, only Lys270 is conserved in
3a-HSD (replaced by an arginine). Lys25 has no compara-
ble counterpart in the 3a-HSD sequence (Fig. 3), but
instead is substituted with Val25, which cannot act as a
hydrogen-bond donor or acceptor. In addition, the nearby
Pro26 cannot form a hydrogen bond (Fig. 4). Although
Asp224 appears to align well, its spatial position is actually
occupied by Ser222 in 3a-HSD (Fig. 4). Ser222 cannot
form a salt bridge, but has the potential of hydrogen
bonding with Arg270. However, conventional difference
and simulated annealing omit electron-density maps
suggest that the hydroxyl of Ser222 points in the opposite
direction and does not form a hydrogen bond with Arg270.
Furthermore, when the serine sidechain was modeled in a
rotamer which made a hydrogen bond with Arg270, it
rotated back to its original position during simulated-
annealing refinement, where it forms a hydrogen bond
with one of the phosphate oxygens.
Based upon sequence similarities, it is likely that other
HSD subfamily members will be similar to 3a-HSD, and
that the salt-linked safety belt is specific to the
aldose/aldehyde reductase subfamilies. As shown in
Figure 3, all HSD subfamily members share a three
residue insertion in the b1–a1 loop and a valine or alanine
substitution at position 25. The residue at position 222
(histidine or glutamine) might act as a hydrogen-bond
acceptor for Lys270, but would not form a salt bridge. 
Structure-based interpretation of the kinetics and catalytic
mechanism
3a-HSD displays a sequential ordered kinetic mechanism,
in which the pyridine nucleotide cofactor binds first and
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leaves last [34]. The ordered bi-bi reaction mechanism can
be understood in terms of the ternary complex structure,
in which the same loops form the cofactor tunnel and the
steroid-binding cavity, and in which the steroid molecule
is packed on top of the nicotinamide ring of the cofactor.
When cofactor binds, there is a partial ordering of the
b1–a1 and B loops in the steroid-binding cavity because
they form the cofactor tunnel. In addition, the nicoti-
namide ring is buried at the base of the steroid-binding
cavity (Fig. 2a). Thus, the structure explains why cofactor
binding must precede steroid hormone binding, and why
no binary enzyme–steroid complexes are observed [34].
Conversely, it explains why cofactor cannot be released
without first releasing the steroid molecule.
Structural and kinetic analysis of aldose reductase sug-
gests there is a conformational rearrangement of loop B
after cofactor binding or before cofactor release [14,32,33,
35,36]. In 3a-HSD, an analogous conformational change
may occur. In both enzymes a conformational rearrange-
ment of loop B will lead to the formation or disruption of
the cofactor tunnel. In 3a-HSD, however, the absence of
a salt-linked safety belt may facilitate the conformational
changes of loop B and the b1–a1 loop that disrupt the
cofactor tunnel. This may explain why loop B was flexi-
ble in the 3a-HSD binary complex, whereas it is well
ordered in the aldose and aldehyde reductase binary com-
plexes. It was previously found that cofactor binding or
release is rate limiting in 3a-HSD [34], which could be
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Figure 3
Sequence alignments of selected regions in
AKR enzymes. Alignments of the (a) b1–a1
loop; (b) loop B; (c) C-terminal tail; and (d)
ligand-binding cavity, where DD is dihydrodiol
dehydrogenase, BABP is bile acid binding
protein, PGS is prostaglandin F2a synthase
and CR is chlordecone reductase. Alignments
were performed based on amino acid
sequences using the GCG package [53]. The
C-terminal tail of aldehyde reductase and the
b1–a1 loop alignments were adjusted based
on the three-dimensional structures. 
related to a slow conformational change of loop B.
However, the flexibility of loop B in the presence of
cofactor suggest that the rate limitation is also a function
of making or breaking the many interactions between the
enzyme and cofactor.
The ternary complex structure also provides insight into
the catalytic mechanism of 3a-HSD. The enzyme is a
class A dehydrogenase which catalyzes direct hydride
transfer of the pro-R hydrogen from the C4 position of the
nicotinamide ring to the acceptor carbonyl at C3 of the
steroid substrate [34]. The ternary complex shows that
this class A specificity is a result of hydrogen bonds
between Ser166, Asn167, Gln190 and the carboxamide
sidechain of nicotinamide. These bonds maintain the
cofactor with its 4-pro-R hydrogen pointing toward the C3
carbon of testosterone. In addition, the enzyme is stere-
ospecific for 3a-hydroxysteroids but not 3b-hydroxys-
teroids (see definitions in Fig. 1 legend). The structure
reveals that the b face of testosterone is directed toward
the nicotinamide ring. Such an arrangement would facili-
tate hydride transfer between the b face of a 3a-hydroxys-
teroid and the nicotinamide ring. Sidechains protruding
into the cavity may prevent 3b-hydroxysteroids from
binding to 3a-HSD ‘upside-down’, with their a faces
toward the nicotinamide ring (discussed below).
The A ring of testosterone is also located near to several
residues that are highly conserved in the AKR superfamily
and proposed to play roles in catalysis [37–39]. One of
these, Tyr55, is conserved in the HSD subfamily with the
exception of the inactive r crystallin (Fig. 3d). In the 3a-
HSD structure, Tyr55 forms a hydrogen bond with the C3
ketone of testosterone (Fig. 2d). Tyr55 appears to act
either as a general acid or to polarize the substrate car-
bonyl without acting as a formal proton donor in the reac-
tion [30] (BP Schlegel, unpublished data). This may be
facilitated by the presence of the conserved Lys84, which
is within hydrogen-bonding distance of Tyr55 and could
depress its pKa. In addition, His117 is highly conserved
and forms a second hydrogen bond with the C3 ketone of
testosterone (Fig. 2d). His117 is thus in a reasonable posi-
tion to play a role in catalysis although the His117→Ala
mutant enzyme retains some activity [30] (BP Schlegel,
unpublished data).
Active site superposition in AKR and SDR enzymes
The SDR and AKR superfamilies are structurally differ-
ent, but functionally similar (reviewed in [40]). As shown
in Table 3, the two superfamilies have different protein
folds, oligomeric states and stereochemistry of hydride
transfer. Surprisingly, however, they catalyze similar, and
in some cases, identical reactions. Moreover,  identical
residues are involved in catalyzing these reactions,
although SDR enzymes use a Tyr-X-X-X-Lys sequence
for catalysis [41–43] and HSDs in the AKR superfamily
use a more widely spaced Tyr/Lys pair (BP Schlegel,
unpublished data).
The 3a-HSD binary complex previously showed that the
active-site residues and portions of the cofactors in SDRs
and AKRs could be superimposed [27]. A comparison of
the ternary complexes of 3a-HSD and 7a-HSD (an SDR
enzyme) [25] now reveals that the ketones and their asso-
ciated rings in the steroids also superimpose quite well
(Fig. 5). The hydroxyl groups of the tyrosine residues are
within 0.7Å of one another, and form a hydrogen bond
with the steroid molecule in each case. Another hydrogen
bond to the steroid is present in both superfamilies,
involving the conserved His117 in AKR enzymes and a
conserved serine in SDR enzymes (Fig. 5). Recently, this
serine residue was shown to be essential for catalysis in
bacterial 3b/17b-HSD [44]. The relative positions of the
lysine residues in both superfamilies are also similar. In
3a-HSD, Lys84 forms a hydrogen bond with Tyr55 and
with Asp50, which interacts with the cofactor. In 7a-HSD,
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Figure 4
Two loops form a cofactor tunnel in 3a-HSD
that is different from that in aldose reductase.
Stereoview figure of 3a-HSD superimposed
with human aldose reductase [14]. The Ca
traces of residues 24–32 and 221–225 in
3a-HSD (thick lines) and residues 24–32 and
221–226 in aldose reductase (thin lines) are
shown (numbering as aligned to 3a-HSD).
The pyrophosphate bridge (P–P) of NADP+ in
3a-HSD is also shown. The ‘safety belt’ in
aldose reductase is shown as a salt bridge
between Asp224, Lys25 and Lys270 and is
indicated with dashed lines. 
P26
D224
S222
K25
V25
K270
R270
NADP (P–P)
P26
D224
S222
K25
V25
K270
R270
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Lys163 is too far away from Tyr159 (4.4 Å) to form a
hydrogen bond; however, it does form a hydrogen bond
with the cofactor [25]. In both cases the nearby lysine
residue may decrease the pKa of the tyrosine residue
and/or stabilize the binding of the cofactor. Although the
roles of the tyrosine/lysine pair and the additional histi-
dine or serine are not fully understood, the superposition
of identical or similar active-site residues and portions of
the cofactor and steroid molecule in both HSD superfami-
lies suggests that these enzymes may have evolved similar
reaction mechanisms.
Steroid hormone recognition
The 3a-HSD ternary complex structure sheds light upon
the general features of steroid hormone recognition by
mammalian HSDs in the AKR superfamily. Our current
understanding of the catalytic mechanism suggests that the
reactive ketone of a steroid molecule must be located near
to the nicotinamide ring from which hydride is transferred,
and must also form hydrogen bonds with the conserved
His117 and Tyr55. Therefore, other HSDs are likely to
bind substrates with their carbonyl groups in similar posi-
tions to that observed in the 3a-HSD ternary complex.
The A ring will be proximal to the active site in 3a-HSDs,
whereas the D ring will be proximal to the active site in
17b-HSD and 20a-HSD. In C18 and C19 steroids, either
the b or a face will be directed towards the nicotinamide
ring to facilitate hydride transfer in reactions involving
either a- or b-oriented hydroxyl groups, respectively. This
will result in the C18 and C19 angular methyl groups being
directed towards either the side of the cavity containing
Trp227 or the side containing residue 54, respectively
(Fig. 6). In C21 steroids, where the reactive group is on a
sidechain, the steroid molecule may be oriented somewhat
differently. Given these loose criteria for substrate binding,
one might expect to find a 3b-HSD, 17a-HSD or 20b-
HSD in the AKR superfamily, although none has been
previously characterized. Such enzymes exist in the SDR
superfamily (Table 3) and there seems to be no structural
reason that precludes the existence of such AKR enzymes.
Substrate selectivity in each HSD will involve both polar
and nonpolar interactions. To a first approximation, the
steroid-binding cavity in 3a-HSD consists of a large, non-
specific apolar surface with a hydrogen-bond network in
the active site that tethers the steroid molecule at one
end. Based on sequence similarity (Fig. 3d) the steroid-
binding cavities in other HSDs will have similar composi-
tions. Although there are ways of increasing substrate
selectivity, as discussed below, the inherent nonspecificity
of the hydrophobic interaction may be a reason that HSDs
bind several substrates or inhibitors. Examples of this
would include the weak 20a-HSD activity observed in
murine liver 17b-HSD [20] or the ability of rat liver 3a-
HSD to turn over structurally diverse substrates [2].
Similar observations have been made for other kinetically
characterized HSDs in the AKR superfamily [5,19]. In
addition, bovine testicular and human brain aldose reduc-
tase, which are not members of the HSD subfamily, have
been shown to display 20a-HSD [45] and isocorticosteroid
reductase activities [46], respectively. 
One way of discriminating between different substrates
and/or orientations would be the formation of an additional
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Figure 5
Superposition of the active sites suggests a
shared reaction mechanism among HSDs of
two superfamilies. Stereoview figure of active-
site residues (red) and testosterone
(magenta) in 3a-HSD superimposed with
active-site residues (dark blue) and the bile
acid 7-oxoglycochenodeoxycholic acid
(GCDCA; cyan) in 7a-HSD (an SDR enzyme)
[25]. The B ring of GCDCA superimposes
with the A ring of testosterone. The A ring of
GCDCA is not visible because it is bent into
the plane of the figure due to the A/B cis ring
fusion in the bile acid. The superposition is
based solely on the nicotinamide ring
positions in both enzymes (not shown for
clarity). The superposition excluded the
carboxamide substituent at the C3 position
because 7a-HSD transfers the pro-S
hydrogen while 3a-HSD transfers the pro-R
hydrogen, so that although the nicotinamide
rings lie in the same plane they are rotated
180° relative to one another. (Figure prepared
with MOLSCRIPT [55] and rendered with
RASTER3D [56,57].)
hydrogen bond with the polar group on the distal end of
the steroid molecule. Additional hydrogen bonds may be
important, or even essential, features of substrate binding
because both ends of the substrate would be tethered and
its rotational freedom greatly reduced. In fact, each
ternary complex in the SDR superfamily shows such an
additional hydrogen bond [23–25]. Although 3a-HSD
does not form a hydrogen bond with the C17 hydroxyl
group in the D ring of testosterone, there are residues
near the cavity that could act as hydrogen-bond donors or
acceptors. A candidate for this function might be residue
226, which is positioned near the D ring of testosterone,
and is a polar residue in several HSDs (Fig. 3).
Another means of substrate discrimination in HSDs is pro-
vided by the sidechains that protrude into the substrate-
binding cavity and may exclude some orientations of
substrates or inhibitors. One such protrusion is formed by
Tyr310 in the C-terminal tail of 3a-HSD, against which
the testosterone molecule packs (Fig. 6a). Tyr310 may
inhibit 3b-HSD or 17b-HSD activity by preventing the
binding of substrates in the proper orientation for cataly-
sis. In contrast to the binding mode observed for testos-
terone, substrates for 3b-HSD or 17b-HSD catalysis
would have to bind so that their a faces were directed
toward the nicotinamide ring and their angular methyl
groups were directed toward the side of the cavity contain-
ing Leu54 (the opposite orientation to that shown in
Fig. 6a). Modeling suggests such binding would produce
steric clashes between the distal ends of steroid substrates
and Tyr310. There is no evidence in the electron-density
maps for such binding and no 3b-HSD or 17b-HSD activ-
ity has been observed in rat liver 3a-HSD [2,47] (JMJ,
unpublished results). However, the modeling and inter-
pretation of sequence substitutions in other HSDs in the
AKR superfamily, such as 17b-HSD, are complicated by
the fact that their C-terminal tails may adopt different
conformations. Large conformational changes in the C-ter-
minal tails of aldose reductase and FR-1 occur in their
complexes with zopolrestat, in which the residue at posi-
tion 310 increases its exposure and Leu308 moves further
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Figure 6
Sidechains in the ligand-binding cavity may determine substrate
selectivity. (a) Space-filling model of the ligand-binding cleft in 3a-
HSD. The testosterone molecule is shown in white. (b) Space-filling
model of the ligand-binding cleft in human aldose reductase [14]. The
glucose-6-phosphate molecule is shown in white. (c) Space-filling
model of the ligand-binding cleft in murine FR-1 [16]; the zopolrestat
molecule is shown in white. Atom coloring is according to atom type:
gray, carbon; blue, nitrogen; red, oxygen; yellow, sulfur; and the
NADP(H) molecule is colored green. The view is rotated ~180° about
the vertical axis relative to Figure 2a. Selected residues in the cavities
and residues discussed in the text are labeled (numbering as aligned
to 3a-HSD).
Table 3
Comparison of HSDs in two superfamilies.
SDR superfamily AKR superfamily
Protein fold a/b type with a Rossmann a/b barrel
dinucleotide-binding fold
Oligomeric state Dimer or tetramer Monomer
Dehydrogenase class B A
Known hydroxysteroid 17b 17b
reactions 3a 3a
3b –
7a –
11b 11b
– 20a
20b –
Catalytic residues Y-X-X-X-K Y-X28-K
Conserved serine Conserved histidine
into the cavity (compare Figs 6b and 6c). Aldehyde reduc-
tase also has a unique C-terminal tail, with a nine residue
loop inserted before position 310 (Fig. 3c).
The residue at position 24 may determine whether an
enzyme is an efficient 3a-HSD. Among the kinetically
characterized 3a-HSDs, the rat liver enzyme has the
highest kcat values for both oxidation and reduction
(Table 4). This activity may be related to the presence of
Thr24 in the binding cavity (Fig. 6a), as opposed to the
Tyr24 found in other HSDs (Fig. 3d). A site-directed
Thr24→Tyr mutant of rat liver 3a-HSD has a kcat of only
7min–1, which is similar to DD2 and DD4 (Table 4).
Moreover, modeling suggests that a tyrosine substitution
would necessitate protein and/or substrate rearrangements
to avoid clashing with the B ring. Based upon the crystal
structure and kinetic data for DD2, DD4 and the
Thr24→Tyr mutant, we suggest that Tyr24 decreases the
rates of 3a-HSD catalysis in DD2 and DD4, perhaps by
altering the position of the steroid substrate.
The region near position 24 also differs between 3a-HSD
and the aldose and aldehyde reductases because of the
different conformation of the b1–a1 loop, which has a
three residue insertion and sequence substitutions
(Fig. 3a). The net result of these changes is that the Ca
atom of position 24 protrudes 1.6 Å further into the cavity
in aldose reductase. In addition, position 24 is a trypto-
phan residue, which also protrudes further into the cavity
(compare Figs 6a and 6b), and would clash with the B ring
of testosterone in the 3a-HSD ternary complex. The only
known HSD activities of aldose reductase involve C21
steroids, which have their reactive groups on a flexible
sidechain and can therefore bind with their D rings further
from position 24. This situation is reminiscent of zopolre-
stat binding in Figure 6c, in which the phthalazine ring is
shifted upwards and rotated to avoid a clash with Trp24.
Other positions in the ligand-binding cavities of AKR
enzymes may be equally, or more important, than positions
24 and 310 in determining substrate-specificity. In the
absence of site-directed mutagenesis data, however, spe-
cific predictions are highly speculative. Instead, our analy-
sis of the active site and steroid-binding cavity in 3a-HSD
identifies some general factors that are likely to be impor-
tant in steroid recognition by HSDs. First, the reactive
carbon (e.g. C3, C17 or C20) should be close to the nicoti-
namide ring to facilitate hydride transfer. Second, the ori-
entation of a C18 or C19 steroid should direct the b or a
face toward the nicotinamide ring for hydride transfer
involving an a- or b-oriented hydroxyl group, respectively;
the orientation of a C21 steroid may be different because
the reactive group will be on a flexible sidechain. Third,
hydrogen bonds between Tyr55 and His117 and the reac-
tive ketone should be formed. Fourth, additional hydro-
gen bond(s) may form between the protein and a distal
polar group on the steroid, so as to tether the steroid in
one orientation. Finally, steric clashes with protruding
sidechains in the cavity should not be formed. In conclu-
sion, we present the ternary complex structure as a model
for HSDs in the AKR superfamily. The structure reveals
residues in the steroid-binding cavity (positions 24, 54, 55,
117, 118, 129, 226, 227, 306 and 310) Fig. 3) that are
potential targets for site-directed mutagenesis studies.
Such studies will hopefully enable us to further under-
stand the roles of these key residues in steroid-recognition
in mammalian HSDs. 
Biological implications
In human and rat liver, isoforms of 3a-hydroxysteroid
dehydrogenase (3a-HSD) inactivate circulating steroid
hormones and play critical roles in bile acid biosynthesis.
In addition, in steroid hormone target tissues, such as the
prostate, 3a-HSDs work in concert with 5a-reductase to
regulate the intracellular concentration of 5a-dihy-
drotestosterone (5a-DHT). 5a-DHT is a potent male sex
hormone (androgen) and is implicated in the pathogenesis
of benign prostate hyperplasia and prostate cancer. Rat
liver 3a-HSD belongs to the aldo-keto reductase (AKR)
superfamily and provides a good model for human liver
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Table 4
Comparison of 3a-HSD activities.
Androsterone Androstanedione 
oxidation* reduction†
Km kcat Km kcat Reference
(mM) (min–1) (mM) (min–1)
Rat liver 3a-HSD 45 66 4 19 [29]
Rat liver 3a-HSD T24Y mutant 62 7 14 4 #
Human type I 3a-HSD (DD4) 1 5 ND‡ 3.4 [5]
Human bile acid binder (DD2) 8 1 ND‡ 0.2 [5]
*Assay conditions: 100 mM potassium phosphate, pH 7.0, 2.3 mM
NAD+ (rat liver 3a-HSD); 100 mM potassium phosphate, pH 7.4,
0.25 mM NADP+ (DD2 and DD4). †Assay conditions: 100 mM
potassium phosphate, pH 7.0, 180 mM NADPH (rat liver 3a-HSD);
100 mM potassium phosphate, pH 7.4, 0.1 mM NADPH (DD2 and
DD4). ‡ND = not determined; #(JMJ, unpublished data). 
and prostatic 3a-HSDs, as well as mammalian 17b- and
20a-HSDs. These HSDs in the AKR superfamily are
functionally related to HSDs in the short-chain dehydro-
genase/reductase (SDR) superfamily, which also regulate
the occupancy of steroid hormone receptors.
This study presents the 2.5 Å resolution structure of
recombinant rat liver 3a-HSD in complex with NADP+
and testosterone (a competitive inhibitor). The structure
provides the first picture of an HSD ternary complex in
the AKR superfamily. It reveals that the C3 ketone in
testosterone, corresponding to the reactive group on a
substrate, is poised above the NADP+ cofactor which is
involved in hydride transfer. The C3 ketone also forms
two hydrogen bonds with active-site residues implicated
in catalysis (Tyr55 and His117). Comparison with
ternary complexes in the SDR superfamily suggests that
enzymes of the two superfamilies may have conver-
gently evolved similar reaction mechanisms.
The model presented here is the only structure to date of
testosterone bound to a protein. It provides insights into
steroid hormone recognition by HSDs as well as adding
to the limited knowledge about protein–steroid hormone
interactions in general. Testosterone is bound in a cylin-
drical cavity, which has a flexible half that is disordered
in the absence of ligand but is ordered and clamped
down in the presence of ligand. Most of the cavity con-
sists of a large apolar surface; however, there is a hydro-
gen-bond network that tethers the C3 ketone of the
steroid molecule in the active site. The model suggests
that substrate selectivity in HSDs may be related to the
protrusions of sidechains into the cavity that exclude
certain orientations of substrates. The ternary complex
provides a model for other mammalian HSDs in the
AKR superfamily and will be useful in the design of site-
directed mutants to study structure and function, as well
as in the design of inhibitors. 
Materials and methods
Purification and crystallization of recombinant 3a-HSD
complexed with NADP+ and testosterone
Recombinant rat liver 3a-HSD overproduced in Escherichia coli was
purified as previously described [29] and stored in a glycerol-contain-
ing buffer (20 mM potassium phosphate, pH 7.0, 1 mM EDTA, 1 mM 2-
mercaptoethanol, 30% glycerol) at –80°C.
The ternary complex of 3a-HSD–NADP+–testosterone was prepared
by forming the binary complex as previously described (adding a tenfold
molar excess of NADP+ during concentration to 10mg ml–1 and buffer
exchange to 10mM potassium phosphate, pH 7.0, 1 mM EDTA, 1 mM
2-mercaptoethanol) [27], and then dialyzing the binary complex against
the same buffer with the addition of 5% acetonitrile and 0.2mM testos-
terone (Sigma) for 24h at 4°C using the ‘waterbug’ dialysis method
[48]. Formation of the ternary complex was verified by performing the
dialysis with radiolabeled [3H]-testosterone (DuPont NEN), and deter-
mining the amount of steroid bound by scintillation counting.
The ternary complex at 10 mg ml–1 was crystallized in the presence of
20–21% polyethylene glycol (PEG) 8000, 0.1 M Na cacodylate, pH
6.4 in 8 ml hanging drops at room temperature. Large, single crystals
(0.5 × 0.3 × 0.05 mm3) grew within 5–7 days. The ternary complex
crystals belong to orthorhombic space group P21212 and have unit cell
dimensions a = 96.4 Å, b = 157.1 Å, c = 49.0 Å.
Crystals used for cryocrystallographic experiments were soaked in arti-
ficial mother liquor (AML) (21% PEG 8000, 0.1 M Na cacodylate,
pH 6.4, 1.25 mM NADP+, 0.1 mM testosterone) with 15% 2-methyl-
2,4-pentanediol (MPD) added as a cryoprotectant. In order to prevent
the crystals from cracking, which occurred when they were directly
transferred to AML plus 15% MPD, we gradually increased the MPD
concentration from 0% to 15% in 5% increments (1 h soaks). Crystals
were mounted in rayon loops (Hampton Research) and flash cooled in
liquid nitrogen before transferring them to a nitrogen gas stream at
–150°C. The cryopreserved and cooled crystals have slightly different
unit cell dimensions: a = 95.0 Å, b = 154.6 Å, c = 48.3 Å809.
Data collection and processing
The ternary complex structure was determined using data sets taken
at room temperature and at –150°C. The room temperature data were
collected from a single crystal (0.3 × 0.3 × 0.04 mm3) with an 18 cm
MAR Research image plate mounted on a rotating-anode X-ray gener-
ator. Data were processed with DENZO and SCALEPACK [49]. 90
degrees were collected with the crystal in one orientation, then the
crystal was re-oriented relative to the rotation axis and 30 degrees
were collected to obtain the data in the missing cone. The data, sum-
marized in Table 2, are 98.2 % complete. This room temperature data
set was used to determine the ternary complex structure, although a
data set collected at –150°C was used at intermediate stages for
model building.
A second data set was collected at –150°C from a single crystal
(0.5 × 0.2 × 0.07 mm3) with an RAXIS-IV image plate mounted on a
rotating-anode X-ray generator and equipped with an X-STREAM
cooling system (Molecular Structure Corporation). Data were
processed using the programs DENZO and SCALEPACK [49]. A
total of 151 923 reflections were merged to give 34 608 out of 35 359
possible unique reflections at 2.2 Å resolution, with Rmerge = 7.2%.
This data set was used to model and refine the protein, but had
partially disordered electron density for the testosterone molecule
(discussed below).
Structure determination
The ternary complex structure was determined by molecular replace-
ment (MR), using the 3a-HSD–NADP+ binary complex coordinates
[27] as a search model. This model included residues 1–311, however,
residues 27–29, 222–224 and 312–322 were disordered. Prior to
performing MR, we deleted residues in three flexible loops which were
suspected to undergo conformational changes upon forming the
ternary complex (residues 124–138 [in loop A], 221–233 [in loop B]
and 304–311 [in the C-terminal tail]) as well as the NADP+ molecule.
Programs in X-PLOR [50] were used to perform MR.
Self-rotation functions using data in several resolution ranges showed
no significant peaks although a second molecule was expected based
on the unit cell dimensions. However, the cross-rotation function using
data in the resolution range 15–4 Å yielded two top solutions (Eulerian
angles u1 = 91.8°, u2 = 86.0°, u3 = 273.7° and u1 = 274.7°, u2 = 82.4°,
u3 = 99.3°). These are related by the spherical angles ψ = 6.8,
φ = 14.7, k = 191.5, which is close to a twofold screw axis about b,
such that the peak in the self-rotation function was masked by the crys-
tallographic twofold axis.
Translation functions with the two cross-rotation function solutions were
calculated using data in the resolution range 15–4 Å. The top two solu-
tions were 12s and 17s above the mean, respectively. These solutions
had fractional coordinates x = 0.23, y = 0.24, z = 0.13 and x = 0.45,
y = 0.05, z = 0.05, respectively. The second solution was translated by
x = 1/2, y = 1/2, z = 0 so the two molecules had a common origin.
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Model building and refinement
Refinement was done using the programs in X-PLOR [50], utilizing
strict noncrystallographic symmetry constraints until the final two
rounds of refinement, when seven residues in crystal contacts were
permitted to deviate from noncrystallographic symmetry, while the
remaining 312 residues were tightly restrained. 
Initially, the MR model was refined for 20 cycles with the entire molecule
modeled as a rigid body, using the room temperature data set in the res-
olution range 8.0–3.5Å. This resulted in a free R factor (Rfree) of 36.3%
and a crystallographic R factor (Rcryst) of 37.3%. The model was then
subjected to three cycles of rebuilding and conjugate gradient minimiza-
tion against data in the resolution range 8.0–2.8Å. Modeling at this stage
included the insertion of residues 305–312 and 314–319 (in the C-ter-
minal tail, of which 312–319 had not been visible in either apoenzyme or
binary complex electron-density maps), insertion of residues 125–131
and 135–138 (in loop A) and inclusion of the NADP+ molecule. This
resulted in an Rfree of 35.6% and Rcryst of 32.1%. In addition, difference
electron density at the active site could be identified as the testosterone
molecule, although it was not included in the coordinates at this stage.
At this point, modeling and refinement were shifted to the –150°C data
set, which was of slightly higher resolution (2.2 Å). Several rounds of
modeling followed by conjugate gradient minimization, simulated anneal-
ing and individual B-factor refinement against data in the resolution
range 8.0–2.2 Å reduced the free and crystallographic R factors to
29.6% and 25.6%, respectively. Changes to the model at this stage
included rebuilding residue 26, inserting residues 27–29, inserting
residues 132–134 (in loop A), inserting residues 313 and 320 (in the
C-terminal tail), inserting residues 222–232 (in loop B) and modeling
water molecules. The criteria for modeling water molecules included the
presence of peaks in 2Fo–Fc and Fo–Fc electron-density maps con-
toured at 1σ and 2σ, respectively, that were related by noncrystallo-
graphic symmetry to peaks in the second molecule in the asymmetric
unit. There were also eight water molecules in crystal contacts. Despite
these improvements to the model, the electron density for testosterone
in the active site was disordered for the distal end of the steroid mol-
ecule. Disorder of the testosterone molecule was observed in another
(25°) data set that was not used in the structure determination, and
probably reflects crystal-to-crystal variations in occupancy.
Therefore, we completed the refinement using the room temperature
data set in which the testosterone molecule was well ordered. In the
first cycle of refining the 2.2 Å resolution model against the room tem-
perature data in the resolution range 8–2.5 Å, we obtained free and
crystallographic R factors of 25.2% and 20.7%, respectively. The unbi-
ased electron-density maps calculated with 2Fo–Fc and Fo–Fc ampli-
tudes and model phases revealed well ordered electron density for the
entire testosterone molecule (Figs 2c, d), which was subsequently
included in the coordinates. The coordinates for testosterone were
obtained from the Cambridge Small Molecules Database [51] and
parameter and topology files were generated using the program
XPLO2D [52]. Seven residues in loops and/or crystal contacts were
permitted to deviate from the noncrystallographic symmetry by refining
the model with loose noncrystallographic symmetry restraints for those
residues and tight restraints for the remaining 312 residues. The final
free and crystallographic R factors are 24.2% and 18.5%, respectively.
Accession numbers
The coordinates of the model have been deposited in the Brookhaven
Protein Data Bank with accession code 1AFS.
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